The FDA's approval of vepdegestrant marks a groundbreaking shift in cancer therapy by introducing PROTAC technology for advanced breast cancer treatment.
Your institution does not have access to this book on JSTOR. Try searching on JSTOR for other items related to this book. https://doi.org/10.2307/j.ctvjnrt76.5 https ...
JOHNSON SPACE CENTER — Even though the IM-1 mission’s lunar lander Odysseus tipped over after landing on the moon last week, the company’s CEO called it a “successful mission” during a press ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results